Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Revenue (Quarterly): 130.23M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 130.23M |
March 31, 2024 | 109.98M |
December 31, 2023 | 99.65M |
September 30, 2023 | 108.53M |
June 30, 2023 | 117.32M |
March 31, 2023 | 107.64M |
December 31, 2022 | 115.52M |
September 30, 2022 | 116.86M |
June 30, 2022 | 121.40M |
March 31, 2022 | 97.12M |
December 31, 2021 | 127.86M |
September 30, 2021 | 113.75M |
June 30, 2021 | 123.20M |
March 31, 2021 | 102.55M |
December 31, 2020 | 106.81M |
September 30, 2020 | 100.80M |
Date | Value |
---|---|
June 30, 2020 | 68.96M |
March 31, 2020 | 61.73M |
December 31, 2019 | 74.64M |
September 30, 2019 | 64.26M |
June 30, 2019 | 64.95M |
March 31, 2019 | 57.12M |
December 31, 2018 | 63.60M |
September 30, 2018 | 50.77M |
June 30, 2018 | 43.55M |
March 31, 2018 | 35.53M |
December 31, 2017 | 198.51M |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 138.73M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
61.73M
Minimum
Mar 2020
130.23M
Maximum
Jun 2024
105.50M
Average
108.53M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
Poseida Therapeutics Inc | 71.75M |
NovaBay Pharmaceuticals Inc | 2.441M |
Palatin Technologies Inc | 0.35M |
iBio Inc | 0.175M |
Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -17.04M |
Total Expenses (Quarterly) | 121.32M |
EPS Diluted (Quarterly) | -0.13 |
Enterprise Value | 560.89M |
Gross Profit Margin (Quarterly) | 77.58% |
Profit Margin (Quarterly) | -13.09% |
Earnings Yield | -3.36% |
Operating Earnings Yield | 2.23% |
Normalized Earnings Yield | 0.0383 |